Safety of specialty medications
Pro Research Analysisby 
Searched over 200M research papers
Specialty Medication Safety: Screening and Monitoring Gaps
Specialty medications, especially immunosuppressive and biologic agents, present unique safety challenges due to their complex mechanisms and potential for serious side effects. Research shows that there are significant gaps in patient safety protocols, particularly in the screening for infections such as latent tuberculosis (LTBI), hepatitis B (HBV), and hepatitis C (HCV) before starting immunosuppressive therapy. In a large health system study, only 62% of patients were screened for LTBI, 42% for HBV, and 33% for HCV, with just 26% receiving all recommended screenings. These gaps were observed across multiple specialties, highlighting the need for more robust and standardized safety protocols to prevent serious adverse events in this high-risk population .
Safety Monitoring Tools: Clinical Dashboards and Pharmacist Interventions
To address safety and adherence issues, some institutions have developed clinical dashboards for monitoring patients on specialty medications, such as tumor necrosis factor (TNF)-α inhibitors. These dashboards help flag patients who may have new infections, overdue laboratory tests, critical lab results, or are overdue for medication refills. In one study, over half of the patients on TNF-α inhibitors were flagged for at least one safety or adherence concern. Pharmacists play a key role in reviewing these flags and intervening to improve patient outcomes. The use of such dashboards, combined with collaborative practice protocols, can enhance the safety and effectiveness of specialty medication therapy .
Risks of Generic Specialty Medications: Underdosing Concerns
The safety of generic specialty medications is also a concern. There have been cases where patients experienced disease exacerbation after switching from a brand-name to a generic specialty medication due to underdosing. For example, a patient with multiple sclerosis had a significant relapse after switching to a generic teriflunomide that contained only 55.5% of the labeled drug amount, well below regulatory standards. This highlights the importance of ensuring quality and consistency in generic specialty medications to prevent patient harm .
Ultra-Complex Specialty Medications: Integrated Pharmacy Models
Some specialty medications are classified as "ultra-complex" due to their extensive requirements for safe use, including additional pre-treatment steps, immunizations, and ongoing monitoring. Managing these medications often requires a multidisciplinary approach, with integrated health-system specialty pharmacies (IHSSPs) playing a central role. IHSSPs coordinate care, ensure compliance with risk evaluation and mitigation strategies (REMS), and provide advanced monitoring to support safe medication initiation and ongoing therapy. Dedicated REMS pharmacists and strong partnerships between health systems and external pharmacies are essential for managing the unique safety challenges of ultra-complex specialty medications .
Medication Safety Strategies: Systematic Approaches
Broader medication safety strategies, such as incident reporting, quality assurance, and the use of safety alerts, are also important for preventing errors with specialty medications. These systematic approaches help identify risks, share lessons learned, and implement best practices across healthcare settings .
Conclusion
Specialty medications offer significant therapeutic benefits but come with increased safety risks that require careful management. Gaps in infection screening, challenges with generic formulations, and the complexity of some therapies highlight the need for robust safety protocols, advanced monitoring tools, and integrated pharmacy models. Collaborative efforts among healthcare providers, pharmacists, and health systems are essential to ensure the safe and effective use of specialty medications 1234+1 MORE.
Sources and full results
Most relevant research papers on this topic
Gaps in Ambulatory Patient Safety for Immunosuppressive Specialty Medications.
Gaps in ambulatory patient safety exist for patients treated with immunosuppressive specialty drugs for diverse inflammatory conditions across all relevant treating specialties.
Development of a specialty medication clinical dashboard to improve tumor necrosis factor-α inhibitor safety and adherence monitoring.
Pharmacists can improve safety and adherence for TNF- inhibitor therapy by using a specialty medication clinical dashboard, which can potentially lead to cost savings and improved patient outcomes.
DOI
Underdosed generic specialty medications: A prescription for patient harm?
Underdosed generic specialty medications, such as teriflunomide, can cause spinal cord exacerbations in multiple sclerosis patients, with 55.5 % content below U.S. FDA specifications.
Ultra-complex specialty medications: Meeting the challenges of significant medication requirements through an integrated specialty pharmacy model.
Integrated health-system specialty pharmacies (IHSSPs) effectively manage ultra-complex specialty medications, ensuring safe medication initiation, appropriate dosing, and monitoring for optimal patient and provider experiences.
DOI
Specialty pharmacy services for patients receiving oral medications for solid tumors.
Specialty pharmacy services are essential for patients receiving oral oncology medications, providing counseling, education, and assistance with copayment assistance programs.
DOI